Viltolarsen: First Approval

Drugs
Sohita Dhillon

Abstract

Viltolarsen (Viltepso® in Japan) is a phosphorodiamidate morpholino antisense oligonucleotide being developed by Nippon Shinyaku, in collaboration with the National Center of Neurology and Psychiatry (NCNP), for the treatment of Duchenne muscular dystrophy (DMD). Viltolarsen binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions. In March 2020, intravenous viltolarsen received its first global approval in Japan for the treatment of DMD in patients with confirmed deletion of the dystrophin gene that is amenable to exon 53 skipping. Viltolarsen is under regulatory review in the USA and clinical trials continue in the USA, Canada and globally. This article summarizes the milestones in the development of viltolarsen leading to the first approval for DMD.

References

Jan 1, 2013·Journal of Personalized Medicine·Joshua J A Lee, Toshifumi Yokota
May 10, 2017·Current Opinion in Pharmacology·Simon Guiraud, Kay E Davies
May 31, 2019·Nature Reviews. Neurology·Ingrid E C Verhaart, Annemieke Aartsma-Rus

❮ Previous
Next ❯

Citations

Jul 22, 2020·Pharmacological Reports : PR·Agnieszka Łoboda, Józef Dulak
Oct 20, 2020·Expert Opinion on Biological Therapy·Anne-Fleur E Schneider, Annemieke Aartsma-Rus
Mar 7, 2021·Pharmaceuticals·Othman Al MusaimiBeatriz G de la Torre
Feb 22, 2021·European Journal of Medicinal Chemistry·Shuo YuanBin Yu
Mar 26, 2021·Nature Reviews. Drug Discovery·Stanley T CrookeXue-Hai Liang
Apr 4, 2021·International Journal of Molecular Sciences·Eriko ToyodaMasato Sato
Apr 3, 2021·Frontiers in Pharmacology·Zhili TianLei Zhang
Apr 7, 2021·EMBO Molecular Medicine·Suzan M HammondVirginia Arechavala-Gomeza
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zhichao TangJingxin Wang
May 1, 2021·Biomedicines·Maria Gagliardi, Ana Tari Ashizawa
May 18, 2021·Neuropathology and Applied Neurobiology·Patricia Soblechero-MartínVirginia Arechavala-Gomeza
Jul 22, 2021·Nature Communications·Chengxi LiBradley L Pentelute
Aug 10, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Douglas B SniderGlenn Cruse
Sep 1, 2021·Journal of Industrial Microbiology & Biotechnology·Evelyn C Mollocana-LaraFernando A Gonzales-Zubiate
Nov 19, 2021·Frontiers in Pharmacology·Theodora MarkatiLaurent Servais

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Annals of Clinical and Translational Neurology
Hirofumi KomakiShinichi Takeda
© 2022 Meta ULC. All rights reserved